Alfred Sandrock

Companies

• Voyager Therapeutics (United States)Chief executive officer Mar 23, 2022 to now¹
• Voyager Therapeutics (United States)President Mar 23, 2022 to now¹
• Voyager Therapeutics (United States)Board member Feb 9, 2022 to now²
• BiogenGrp SVP, Chief Medical Officer Jun 10, 2013 to Jun 9, 2021³
• Neurocrine BiosciencesBoard member Sep 4, 2015 to May 23, 2019⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Voyager Therapeutics (United States) VYGR472,549 shares⁵$971.1K at $2.06Apr 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 2, 2026Sold 11,511 shares at $3.87 of Voyager Therapeutics (United States)⁵
• Feb 24, 2026Sold 14,197 shares at $3.79 of Voyager Therapeutics (United States)⁶
• Feb 18, 2026Sold 11,732 shares at $3.41 of Voyager Therapeutics (United States)⁷
• Feb 10, 2026Sold 12,192 shares at $3.78 of Voyager Therapeutics (United States)⁸
• Feb 6, 2026Granted 86,250 shares of Voyager Therapeutics (United States)⁹
• Apr 2, 2025Sold 10,885 shares at $3.43 of Voyager Therapeutics (United States)¹⁰
• Feb 21, 2025Granted 145,000 shares of Voyager Therapeutics (United States)¹¹
• Feb 20, 2025Sold 11,702 shares at $4.24 of Voyager Therapeutics (United States)¹¹
• Feb 11, 2025Sold 16,644 shares at $4.45 of Voyager Therapeutics (United States)¹²
• Apr 2, 2024Sold 12,115 shares at $9.86 of Voyager Therapeutics (United States)¹³
• Feb 21, 2024Sold 13,033 shares at $7.46 of Voyager Therapeutics (United States)¹⁴
• Feb 9, 2024Granted 130,000 shares of Voyager Therapeutics (United States)¹⁵
• Apr 3, 2023Sold 7,437 shares at $7.83 of Voyager Therapeutics (United States)¹⁶
• Feb 17, 2023Granted 120,000 shares of Voyager Therapeutics (United States)¹⁷
• Mar 22, 2022Granted 100,000 shares of Voyager Therapeutics (United States)¹⁸